| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/09/2013 | CN102861076A Application of Houttuynoid A in antibacterial medicine |
| 01/09/2013 | CN102861075A Application of Houttuynoid B in medicine for treating gastric cancer |
| 01/09/2013 | CN102861074A Application of Houttuynoid B in medicine for treating bladder cancer |
| 01/09/2013 | CN102861073A Application of Houttuynoid A in medicine for treating colorectal cancer |
| 01/09/2013 | CN102861072A Application of Houttuynoid A in medicine for treating or preventing renal fibrosis |
| 01/09/2013 | CN102861071A Application of Houttuynoid A in medicine for treating gastric cancer |
| 01/09/2013 | CN102861070A Application of Houttuynoid E in medicine for treating tongue cancer |
| 01/09/2013 | CN102861069A Application of Houttuynoid B in medicine for treating laryngocarcinoma |
| 01/09/2013 | CN102861068A Application of Houttuynoid D in medicine for preventing and treating liver injury |
| 01/09/2013 | CN102861067A Application of Houttuynoid E in anti-helicobacter pylori (Hp) medicine |
| 01/09/2013 | CN102861066A Application of Houttuynoid C in medicine for preventing and treating liver injury |
| 01/09/2013 | CN102861065A Application of Houttuynoid E in medicine for treating gastric cancer |
| 01/09/2013 | CN102861064A Application of Houttuynoid E in medicine for treating laryngocarcinoma |
| 01/09/2013 | CN102861063A Application of Houttuynoid C in medicine for treating or preventing renal fibrosis |
| 01/09/2013 | CN102861062A Application of Houttuynoid C in endometrial cancer treatment medicine |
| 01/09/2013 | CN102861061A Application of Houttuynoid B in cholangiocarcinoma treatment medicine |
| 01/09/2013 | CN102861060A Application of Houttuynoid B in leukemia treatment medicine |
| 01/09/2013 | CN102861059A Application of Houttuynoid D in pancreatic cancer treatment medicine |
| 01/09/2013 | CN102861058A Application of Houttuynoid D in cholangiocarcinoma treatment medicine |
| 01/09/2013 | CN102861057A Application of Houttuynoid D in skin cancer treatment medicine |
| 01/09/2013 | CN102861056A Application of Houttuynoid A in endometrial cancer treatment medicine |
| 01/09/2013 | CN102861055A Application of Houttuynoid A in helicobacter pylori resisting medicine |
| 01/09/2013 | CN102861054A Application of Houttuynoid D in medicine for inhibiting liver fibroblast proliferation |
| 01/09/2013 | CN102861053A Application of Houttuynoid D in leukemia treating medicine |
| 01/09/2013 | CN102861052A Application of Houttuynoid A in medicine for treating ileocecum cancer |
| 01/09/2013 | CN102861051A Application of Houttuynoid A in medicine for treating renal cancer |
| 01/09/2013 | CN102861050A Application of Houttuynoid A in medicine for treating pancreatic cancer |
| 01/09/2013 | CN102861049A Application of Houttuynoid A in medicine for treating liver cancer |
| 01/09/2013 | CN102861048A Application of Houttuynoid A in medicine for treating nasopharyngeal carcinoma |
| 01/09/2013 | CN102861047A Application of Gypensapogenin A in medicine for preventing respiratory syncytial virus |
| 01/09/2013 | CN102861046A Application of Houttuynoid A in ovarian cancer treatment medicine |
| 01/09/2013 | CN102861045A Medicinal composition for treating neuropathic pain |
| 01/09/2013 | CN102861044A Novel application of himalayan teasel root chemical compositions |
| 01/09/2013 | CN102861043A Application of catalpol in preparation of medicine for treating ischemic cerebral apoplexy sequelae |
| 01/09/2013 | CN102861042A Novel application of catalpol |
| 01/09/2013 | CN102861041A New application of echinacoside |
| 01/09/2013 | CN102861040A Medicine composition containing aspirin, acetaminophen and caffeine and preparation method thereof |
| 01/09/2013 | CN102861039A Medicinal formulation for treating beriberi |
| 01/09/2013 | CN102861038A Pharmaceutical formulation for treating psoriasis |
| 01/09/2013 | CN102861037A Application of Gypensapogenin B in medicine for treating atherosclerosis |
| 01/09/2013 | CN102861036A Application of Gypensapogenin B in medicine for treating chronic obstructive pulmonary disease |
| 01/09/2013 | CN102861035A Application of Gypensapogenin B in medicine for treating myocardial ischemia |
| 01/09/2013 | CN102861034A Application of Gypensapogenin A in medicine for treating or preventing acute heart failure |
| 01/09/2013 | CN102861033A Application of Gypensapogenin A in medicine for treating acute gout |
| 01/09/2013 | CN102861032A Application of Gypensapogenin A in medicine for treating rheumatoid arthritis |
| 01/09/2013 | CN102861031A Application of Gypensapogenin B in medicine for resisting respiratory syncytial virus |
| 01/09/2013 | CN102861030A Application of Gypensapogenin B in medicine for treating acute gout |
| 01/09/2013 | CN102861029A Application of Gypensapogenin B in medicine for treating hemorrhagic fever with renal syndrome |
| 01/09/2013 | CN102861028A Application of Gypensapogenin B in medicine for preventing or treating pancreatic fibrosis |
| 01/09/2013 | CN102861027A Application of Gypensapogenin A in medicine for preventing human fungi |
| 01/09/2013 | CN102861026A Application of Gypensapogenin A in medicine for treating influenza virus A |
| 01/09/2013 | CN102861025A Application of Gypensapogenin B in medicine for treating Dengue virus infection |
| 01/09/2013 | CN102861024A Application of Gypensapogenin A in medicine for increasing white blood cell |
| 01/09/2013 | CN102861023A Application of saringosterol |
| 01/09/2013 | CN102861022A Hydrochloric acid vilazodone compound preparation |
| 01/09/2013 | CN102861021A Dry powder spray for rhinitis |
| 01/09/2013 | CN102861020A Application of folic acid on preparation of medicine for preventing initial colorectal adenoma |
| 01/09/2013 | CN102861019A Method of treatment or prophylaxis |
| 01/09/2013 | CN102861018A Pitavastatin calcium preparation and preparation technology |
| 01/09/2013 | CN102861017A Application of compound on prevention and treatment of senile dementia |
| 01/09/2013 | CN102861016A Application of jatrorrhizine for treating candida albicans infectious diseases |
| 01/09/2013 | CN102861015A Stable amoxicillin and clavulanate potassium sustained release preparation and preparation technology |
| 01/09/2013 | CN102861014A Worm-disease-resisting compound niclosamide tablet for beasts and birds and preparation method thereof |
| 01/09/2013 | CN102861013A Pharmaceutical composition and preparation of 17 amino acids |
| 01/09/2013 | CN102861012A Medicine composition containing 18 amino acids and preparation thereof |
| 01/09/2013 | CN102861011A Medicine composition of 18 amino acids and preparation |
| 01/09/2013 | CN102861010A Imidafenacin pharmaceutical composition with improved oral-taking absorbency |
| 01/09/2013 | CN102861009A Application of L-ascorbic acid in preparation of drug having antagonistic action on cytotoxicity effect caused by cyanea capillata toxin |
| 01/09/2013 | CN102861008A Application of Aphanamixoid A in medicine for treating acute renal failure |
| 01/09/2013 | CN102861007A Application of Aphanamixoid A in antidepressant medicine |
| 01/09/2013 | CN102861006A Application of Eryngiolide A in medicine for preventing and curing liver injury |
| 01/09/2013 | CN102861005A Application of Eryngiolide A in medicine for promoting small intestine peristalsis |
| 01/09/2013 | CN102861004A Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
| 01/09/2013 | CN102861003A Application of carnosic acid and its pharmaceutically acceptable salts in preparing medicines for preventing or treating cerebral infarction |
| 01/09/2013 | CN102861002A Application and determining method of zinc ion as alpha-glucosidase inhibitor |
| 01/09/2013 | CN102861001A Novel application of cinnamic aldehyde for treating gastritis |
| 01/09/2013 | CN102861000A Preparation process of dimethyl sulfoxide flushing fluid |
| 01/09/2013 | CN102860999A 1-deoxidation-D-xylulose5-phosphoric acid reduction isomerization enzyme inhibitor and preparation method thereof |
| 01/09/2013 | CN102860998A New application of taxol and taxol nasal delivery preparation |
| 01/09/2013 | CN102860997A Ondansetron oral cavity instant membrane capable of sheltering taste and preparation method thereof |
| 01/09/2013 | CN102860996A Method for preparing lycoypene microcapsule |
| 01/09/2013 | CN102860995A Enrofloxacin effervescent granule for livestock and preparation method thereof |
| 01/09/2013 | CN102860994A Rosuvastatin calcium tablet and preparation method |
| 01/09/2013 | CN102860993A Hydrochloric acid vilazodone quick-release tablet and preparation method thereof |
| 01/09/2013 | CN102860992A Tiacumicins B sustained release or controlled release composition orally taken for one time per day |
| 01/09/2013 | CN102860991A Medicine composition containing febuxostat and preparation method thereof |
| 01/09/2013 | CN102860990A Cefetamet pivoxil hydrochloride dispersible tablet and preparation method thereof |
| 01/09/2013 | CN102860989A Two formulations of chiral drug R/S (+/-)-1-[4-(2-methoxyphenyl) piperazinyl]-3-(1-naphthyloxyl)-2-propanol optical isomer |
| 01/09/2013 | CN102860987A Diclofenac sodium sustained-release capsule and preparation method thereof |
| 01/09/2013 | CN102860986A Stable taste-masking levocetirizine medicine composition and preparation method thereof |
| 01/09/2013 | CN102860985A Tebipenem pivoxil oral preparation and preparation method thereof |
| 01/09/2013 | CN102860984A Method for preparing compound sulfachloropyridazine sodium powder |
| 01/09/2013 | CN102860983A Novel pharmaceutical composition of 2-(4- isobutylphenyl) propionic acid |
| 01/09/2013 | CN102860982A Tilianin microemulsion composition |
| 01/09/2013 | CN102860981A Schistosomiasis resistant praziquantel transdermal solution for flocks and herds and preparation method |
| 01/09/2013 | CN102860980A Method for preparing rocuronium bromide injection |
| 01/09/2013 | CN102860925A Application of theaflavin to preparation of tyrosinase inhibitor |
| 01/09/2013 | CN102860778A Food sterilization wet wipe suitable for hand-mouth contact |
| 01/09/2013 | CN102860520A Novel nutraceutical compositions |
| 01/09/2013 | CN102552178B Lyophilized powder injection of rabeprazole sodium medicinal composition and preparation method of lyophilized powder injection |